Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Jusung Engineering (036930) – Decision on Conclusion of Trust Contract for Acquisition of Treasury Shares / 2024-10-29

Posted on October 29, 2024August 3, 2026 By K-STOCK Editor No Comments on [Disclosure] Jusung Engineering (036930) – Decision on Conclusion of Trust Contract for Acquisition of Treasury Shares / 2024-10-29

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Jusung Engineering has resolved to enter into a KRW 50B trust contract with Eugene Investment & Securities to acquire treasury shares, aiming to enhance shareholder value and stabilize its stock price.

📊 [Key Disclosure Contents & Major Figures Summary]

  • Disclosure Title: Decision on Conclusion of Trust Contract for Acquisition of Treasury Shares
  • Contract Amount: KRW 50,000,000,000 (KRW 50B)
  • Contract Period: 2024-10-29 to 2025-04-29
  • Contract Purpose: Enhancement of shareholder value and stabilization of stock price
  • Contracting Trust Institution: Eugene Investment & Securities Co., Ltd.
  • Expected Contract Date & Board Resolution Date: 2024-10-29
  • Current Treasury Shares Held: 0 shares (The previously held 980,891 shares were fully canceled on July 18, 2024)
  • Maximum Legal Limit for Treasury Share Acquisition: KRW 128,298,982,864

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Actual Treasury Share Acquisition Progress Under the Trust Agreement

This disclosure outlines the company’s decision to enter into a KRW 50B trust contract for treasury stock acquisition with Eugene Investment & Securities through April 29, 2025. Verifying the actual acquisition progress under the trust agreement is important for understanding whether the execution of the contract is proceeding as planned. The progress and results of the share acquisitions can be verified through official periodic reports (Annual, Half-Year, or Quarterly Reports) and the official report filed upon the termination of the trust contract on the DART system.

📢 Disclaimer & Source Notice

Source: This content has been re-structured and authored based on official data submitted to the Financial Supervisory Service’s DART system.

Investment Risk Warning: This material is provided strictly for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Jusung Engineering (036930) – Withdrawal of Decision on Corporate Spin-off / 2024-10-29
Next Post: [Disclosure] Jusung Engineering (036930) – (Correction) Decision on Corporate Spin-off (Physical Spin-off – Withdrawal) / 2024-10-29

Related Posts

[Disclosure] Hanwha Ocean (042660) Refiles Unconfirmed Clarification Regarding Rumor of Australian Defense Firm ‘Austal’ Acquisition, Stating “No Further Progress” Disclosures
[Disclosure] Samsung Biologics (207940) – Consolidated Financial Results (Preliminary) / 2026-07-23 Disclosures
[Disclosure] SK Hynix (000660) – Other Management Decisions (Voluntary Disclosure) / 2024-11-27 Semiconductors
[Disclosure] Samsung Electro-Mechanics (009150) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-03-19 Semiconductors
[Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04 Disclosures
[Disclosure] Jusung Engineering (036930) – (Correction) Decision on Corporate Spin-off (Physical Spin-off – Withdrawal) / 2024-10-29 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme